Literature DB >> 10828877

Toxoplasmosis after hematopoietic stem transplantation. Report of a 5-year survey from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

R Martino, S Bretagne, M Rovira, A J Ullmann, J Maertens, T Held, E Deconinck, C Cordonnier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10828877     DOI： 10.1038/sj.bmt.1702396

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  12 in total

1.  Arboprotozoae.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

Review 2.  Toxoplasmosis: A history of clinical observations.

Authors:  Louis M Weiss; Jitender P Dubey
Journal:  Int J Parasitol       Date:  2009-02-13       Impact factor: 3.981

3.  Toxoplasmosis disease in paediatric hematopoietic stem cell transplantation: do not forget it still exists.

Authors:  N Decembrino; A Comelli; F Genco; A Vitullo; S Recupero; M Zecca; V Meroni
Journal:  Bone Marrow Transplant       Date:  2017-06-12       Impact factor: 5.483

Review 4.  Opportunistic infections of the central nervous system in the transplant patient.

Authors:  Bruce A Cohen; Valentina Stosor
Journal:  Curr Neurol Neurosci Rep       Date:  2013-09       Impact factor: 5.081

5.  Real-time PCR for diagnosis and follow-up of Toxoplasma reactivation after allogeneic stem cell transplantation using fluorescence resonance energy transfer hybridization probes.

Authors:  J M Costa; C Pautas; P Ernault; F Foulet; C Cordonnier; S Bretagne
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

6.  Timely diagnosis of disseminated toxoplasmosis by sputum examination.

Authors:  Sophy Laibe; Stéphane Ranque; Catherine Curtillet; Françoise Faraut; Henri Dumon; Jacqueline Franck
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

7.  Molecular diagnosis of toxoplasmosis in immunocompromised patients: a 3-year multicenter retrospective study.

Authors:  Florence Robert-Gangneux; Yvon Sterkers; Hélène Yera; Isabelle Accoceberry; Jean Menotti; Sophie Cassaing; Marie-Pierre Brenier-Pinchart; Christophe Hennequin; Laurence Delhaes; Julie Bonhomme; Isabelle Villena; Emeline Scherer; Frédéric Dalle; Feriel Touafek; Denis Filisetti; Emmanuelle Varlet-Marie; Hervé Pelloux; Patrick Bastien
Journal:  J Clin Microbiol       Date:  2015-03-11       Impact factor: 5.948

Review 8.  Disseminated toxoplasmosis in non-allografted patients with hematologic malignancies: report of two cases and literature review.

Authors:  S Scerra; H Coignard-Biehler; F Lanternier; F Suarez; C Charlier-Woerther; M-E Bougnoux; J Gilquin; M Lecuit; O Hermine; O Lortholary
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-18       Impact factor: 3.267

9.  [Female patient with organic psychosyndrome and neurological focal signs after immunosuppressant therapy].

Authors:  P Kühnlein; M Ringhoffer; H Tumani; H J Gdynia
Journal:  Internist (Berl)       Date:  2008-01       Impact factor: 0.743

10.  Late-Onset Cerebral Toxoplasmosis After Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Ahmed M Khalaf; Mahmoud A Hashim; Mohammed Alsharabati; Kenneth Fallon; Joel K Cure; Peter Pappas; Shin Mineishi; Ayman Saad
Journal:  Am J Case Rep       Date:  2017-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.